“Corporate Governance, Capital Structure, and Financial Performance: Investigating the Moderating Role of Financial Risk in Pakistan’s Pharmaceutical Industry”, AMAR, vol. 4, no. 3, pp. 306–321, Mar. 2026, doi: 10.66021/.